메뉴 건너뛰기




Volumn 44, Issue 14-15, 2011, Pages 1264-1266

Tumor-induced osteomalacia: The tumor may stay hidden!

Author keywords

FGF 23; Osteomalacia

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; DIPYRIDAMOLE; DISODIC PHOSPHATE; FIBROBLAST GROWTH FACTOR 23; OXIDRONATE TECHNETIUM TC 99M; PHOSPHATE; PHOSPHORIC ACID; UNCLASSIFIED DRUG; VITAMIN D;

EID: 80052941420     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.07.013     Document Type: Article
Times cited : (12)

References (13)
  • 1
    • 77953950024 scopus 로고    scopus 로고
    • Genetic disorders of renal phosphate transport
    • Prie D., Friedlander G. Genetic disorders of renal phosphate transport. N Engl J Med 2010, 362:2399-2409.
    • (2010) N Engl J Med , vol.362 , pp. 2399-2409
    • Prie, D.1    Friedlander, G.2
  • 2
    • 79952760461 scopus 로고    scopus 로고
    • Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease
    • Filler G., Liu D., Huang S.H., Casier S., Chau L.A., Madrenas J. Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease. Clin Biochem 2011, 44:435-437.
    • (2011) Clin Biochem , vol.44 , pp. 435-437
    • Filler, G.1    Liu, D.2    Huang, S.H.3    Casier, S.4    Chau, L.A.5    Madrenas, J.6
  • 3
    • 14944360740 scopus 로고    scopus 로고
    • Octreotide therapy for tumor-induced osteomalacia
    • Seufert J., Ebert K., Muller J., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001, 345:1883-1888.
    • (2001) N Engl J Med , vol.345 , pp. 1883-1888
    • Seufert, J.1    Ebert, K.2    Muller, J.3
  • 4
    • 70350707962 scopus 로고    scopus 로고
    • Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour
    • Radaideh A.R., Jaradat D., Abu-Kalaf M.M., Nusier M.K. Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour. Curr Oncol 2009, 16:87-90.
    • (2009) Curr Oncol , vol.16 , pp. 87-90
    • Radaideh, A.R.1    Jaradat, D.2    Abu-Kalaf, M.M.3    Nusier, M.K.4
  • 5
    • 38949151685 scopus 로고    scopus 로고
    • Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1
    • Hannan F.M., Athanasou N.A., Teh J., Gibbons C.L., Shine B., Thakker R.V. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 2008, 158:265-271.
    • (2008) Eur J Endocrinol , vol.158 , pp. 265-271
    • Hannan, F.M.1    Athanasou, N.A.2    Teh, J.3    Gibbons, C.L.4    Shine, B.5    Thakker, R.V.6
  • 6
    • 15544385175 scopus 로고    scopus 로고
    • Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case
    • Dupond J.L., Mahammedi H., Prie D., et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone 2005, 36:375-378.
    • (2005) Bone , vol.36 , pp. 375-378
    • Dupond, J.L.1    Mahammedi, H.2    Prie, D.3
  • 7
    • 4043052503 scopus 로고    scopus 로고
    • Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
    • Takeuchi Y., Suzuki H., Ogura S., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004, 89:3979-3982.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3979-3982
    • Takeuchi, Y.1    Suzuki, H.2    Ogura, S.3
  • 9
    • 79958866008 scopus 로고    scopus 로고
    • Selective venous catheterization for the localization of phosphaturic mesenchymal tumors
    • Andreopoulou P., Dumitrescu C.E., Kelly M.H., et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 2011, 26:1295-1302.
    • (2011) J Bone Miner Res , vol.26 , pp. 1295-1302
    • Andreopoulou, P.1    Dumitrescu, C.E.2    Kelly, M.H.3
  • 10
    • 1842685810 scopus 로고    scopus 로고
    • Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia
    • Kimizuka T., Ozaki Y., Sumi Y. Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia. Ann Nucl Med 2004, 18:63-67.
    • (2004) Ann Nucl Med , vol.18 , pp. 63-67
    • Kimizuka, T.1    Ozaki, Y.2    Sumi, Y.3
  • 11
    • 33845964211 scopus 로고    scopus 로고
    • Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography
    • Hesse E., Moessinger E., Rosenthal H., et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 2007, 22:158-162.
    • (2007) J Bone Miner Res , vol.22 , pp. 158-162
    • Hesse, E.1    Moessinger, E.2    Rosenthal, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.